Recent trends in epistaxis management in the United States: 2008-2010

JA Villwock, K Jones - JAMA Otolaryngology–Head & Neck …, 2013 - jamanetwork.com
Importance The treatment of epistaxis is variable. It is important to analyze the effect of the
available interventions on patient outcomes. Objective To determine demographic …

Thyroid disorders in chronic heart failure: from prognostic set-up to therapeutic management

V Triggiani, M Iacoviello - Endocrine, Metabolic & Immune …, 2013 - ingentaconnect.com
Thyroid hormones have relevant activity at cardiac and vascular level, by influencing heart
rate, myocardial excitability as well as inotropic and lusitropic status, systemic vascular …

The mean platelet volume is positively correlated with serum thyrotropin concentrations in a population of healthy subjects and subjects with unsuspected subclinical …

JH Kim, JH Park, SY Kim, HY Bae - Thyroid, 2013 - liebertpub.com
Background: A possible prothrombotic effect of elevated thyrotropin (TSH) has been
suggested. The mean platelet volume (MPV), which is used to measure the platelet size, can …

Arterial and venous thrombosis in endocrine diseases

B van Zaane, DJF Stuijver, A Squizzato… - … in thrombosis and …, 2013 - thieme-connect.com
Endocrine diseases have been associated with cardiovascular events. Both altered
coagulation and fibrinolysis markers and thrombotic disorders have been described in …

Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature

L Tomisti, M Del Re, L Bartalena, ML Tanda, A Pucci… - Endocrine Practice, 2013 - Elsevier
Objective To review the literature regarding the interaction among amiodarone therapy,
thyroid hormone levels, and warfarin metabolism. Methods 73-year-old male with type 2 …

Optimal treatment duration of venous thrombosis

W Ageno, F Dentali, MP Donadini… - Journal of Thrombosis …, 2013 - Wiley Online Library
Randomized controlled trials have shown that patients with venous thromboembolism
benefit from a minimum of three months of anticoagulant therapy. After this period, it was …

Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia

CJN Verkleij, DJF Stuijver, B van Zaane… - Thrombosis and …, 2013 - thieme-connect.com
Endocrine disorders affect both the coagulation and fibrinolytic systems, and have been
associated with the development of cardiovascular diseases. Thrombin-activatable …

Cerebral venous sinus thrombosis with autoimmune thyroiditis

S Aggarwal, N Sharma - Indian Journal of Endocrinology and …, 2013 - journals.lww.com
Abstract Cerebral Venous Thrombosis (CVT) is a multifactorial condition which is described
as idiopathic in 12.5% of patients. Hyperthyroidism has been associated with CVT in many …

Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases

S Grine, N Charfi, M Kamoun, F Mnif… - Indian Journal of …, 2013 - journals.lww.com
Several disorders of coagulation and fibrinolysis have been widely reported in patients with
hyperthyroidism. Most reports have focused on only the venous thromboembolism risk, and …

[PDF][PDF] Platelet function in euthyroid patients undergoing thyroidectomy in women

A Alcelik, G Aktas, M Eroglu, M Tosun… - Eur Rev Med …, 2013 - academia.edu
BACKGROUND: Several studies have reported several platelet abnormalities in patients
with sub-clinical or overt thyroid dysfunctions. The primary mechanism that affects the …